Document Detail


Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
MedLine Citation:
PMID:  7755939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effect of intensified blood pressure (BP) control with a reduction of the diastolic BP to < or = 85 mm Hg on renal function and urinary albumin excretion (UAE) was studied in 28 men with primary hypertension (aged 62 to 72 years) treated for 13 +/- 5 years with beta-blockade, diuretics, or hydralazine. They were compared with 25 normotensive (NT) men of similar age. At baseline (BL), glomerular filtration rate (GFR), renal plasma flow (RPF) (clearance of inulin and para-aminohippurate), and the UAE were studied. Thereafter, all antihypertensive drugs except beta-blockers were withdrawn and either felodipine (5 to 20 mg; n = 13) or ramipril (2.5 to 10 mg; n = 15) was added in a double blind, randomized fashion. Hydrochlorothiazide was added if necessary. The investigations were repeated after 6 weeks and 1 year of double-blind treatment. At BL, the BP and the renal vascular resistance (RVR) were significantly higher and GFR and RPF were significantly lower in both hypertensive groups than in NT. After 1 year, the BP treatment goal was reached by all patients in the felodipine group but only by two-thirds in the ramipril group in spite of addition of diuretics to 60% of the latter group. In the felodipine group, the BP, GFR, and RVR after 1 year no longer differed significantly from normal. The UAE and the fractional albumin clearance increased significantly after 1 year's treatment in the felodipine group but did not change in the ramipril group. The fractional albumin clearance, however, did not differ significantly from normal either at BL or after 1 year's treatment in any of the hypertensive groups. It is therefore possible to reduce BP and improve renal function in primary hypertension to levels not significantly different from normal after treatment with felodipine in combination with beta-blockade. Although this regimen increased the low UAE slightly, the fractional albumin clearance changed less and did not differ significantly from normal. The ramipril/beta-blocker combination reduced BP less and did not change the slightly reduced renal function or the UAE.
Authors:
A Siewert-Delle; S Ljungman; M Hartford; J Wikstrand
Related Documents :
15001199 - Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamid...
10574419 - The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide ...
9535429 - Hypertension optimal treatment (hot) study: home blood pressure in treated hypertensive...
3276279 - Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the el...
8105829 - Fenoldopam infusion for the treatment of postoperative hypertension.
19920269 - Two self-management interventions to improve hypertension control: a randomized trial.
3053589 - Effect of perivascular electromagnetic flow probes on pulmonary hemodynamics.
277049 - Characterization of glycogen in selected tissues of turkey poults with spontaneous roun...
3880999 - Pattern of left ventricular diastolic filling in chronic aortic regurgitation: a gated ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of hypertension     Volume:  8     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1995 Feb 
Date Detail:
Created Date:  1995-06-29     Completed Date:  1995-06-29     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  113-23     Citation Subset:  IM    
Affiliation:
Department of Nephrology, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Aged
Albuminuria / drug therapy,  physiopathology,  urine*
Blood Pressure / drug effects,  physiology*
Drug Therapy, Combination
Felodipine / therapeutic use*
Follow-Up Studies
Glomerular Filtration Rate / drug effects
Humans
Hypertension / drug therapy,  physiopathology*,  urine
Kidney / drug effects,  physiopathology*
Male
Middle Aged
Ramipril / therapeutic use*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 72509-76-3/Felodipine; 87333-19-5/Ramipril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blunted attenuation of angiotensin II-mediated Ca2+ transients by insulin in cultured unpassaged vas...
Next Document:  Association of increased erythrocyte Na+/H+ exchanger with renal Na+ retention in patients with esse...